66 participants
Phase II Trial of FOLFOX6, Bevacizumab and Cetuximab in Patients With Colorectal Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2015-07-27
- Start Date:
- 2004-11-30
- Completion:
- 2011-07-31
Conditions
- Adenocarcinoma of the Rectum
- Mucinous Adenocarcinoma of the Colon
- Recurrent Colon Cancer
- Recurrent Rectal Cancer
- Signet Ring Adenocarcinoma of the Colon
- Stage IV Colon Cancer
- Stage IV Rectal Cancer
Interventions
- BIOLOGICAL
- DRUG